Gene Symbol | Gene ID | Gene Info |
---|---|---|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_2770236_2770387 | WRNIP1 | 1304 | 0.466298 | 0.74 | 2.4e-02 | Click! |
chr6_2795862_2796013 | WRNIP1 | 26930 | 0.154778 | 0.69 | 3.8e-02 | Click! |
chr6_2761476_2761627 | WRNIP1 | 4097 | 0.233748 | -0.55 | 1.2e-01 | Click! |
chr6_2791931_2792082 | WRNIP1 | 22999 | 0.165006 | 0.50 | 1.7e-01 | Click! |
chr6_2764369_2764520 | WRNIP1 | 1204 | 0.495117 | -0.46 | 2.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_107956832_107957922 | 0.95 |
DKK2 |
dickkopf WNT signaling pathway inhibitor 2 |
77 |
0.99 |
chr2_160918347_160919586 | 0.92 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr7_37960238_37961117 | 0.91 |
EPDR1 |
ependymin related 1 |
245 |
0.94 |
chr16_73081294_73081963 | 0.91 |
ZFHX3 |
zinc finger homeobox 3 |
646 |
0.76 |
chr19_709173_709581 | 0.91 |
PALM |
paralemmin |
276 |
0.84 |
chr19_6740138_6741070 | 0.88 |
TRIP10 |
thyroid hormone receptor interactor 10 |
325 |
0.81 |
chr2_152955295_152956035 | 0.86 |
CACNB4 |
calcium channel, voltage-dependent, beta 4 subunit |
72 |
0.94 |
chr15_40530958_40531718 | 0.86 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
46 |
0.96 |
chr3_112929944_112930573 | 0.85 |
BOC |
BOC cell adhesion associated, oncogene regulated |
71 |
0.98 |
chr6_88875424_88876640 | 0.80 |
CNR1 |
cannabinoid receptor 1 (brain) |
46 |
0.99 |
chr1_180881914_180882730 | 0.78 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr7_145813028_145813349 | 0.76 |
CNTNAP2 |
contactin associated protein-like 2 |
265 |
0.94 |
chr16_74440490_74441404 | 0.76 |
CLEC18B |
C-type lectin domain family 18, member B |
14343 |
0.14 |
chr1_14924992_14926197 | 0.75 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr18_28681584_28682412 | 0.75 |
DSC2 |
desmocollin 2 |
31 |
0.88 |
chr19_45995836_45996758 | 0.75 |
RTN2 |
reticulon 2 |
228 |
0.87 |
chr1_75138923_75139762 | 0.74 |
C1orf173 |
chromosome 1 open reading frame 173 |
80 |
0.98 |
chr4_71570546_71572213 | 0.74 |
RUFY3 |
RUN and FYVE domain containing 3 |
861 |
0.36 |
chr6_78172796_78173983 | 0.73 |
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
101 |
0.99 |
chr10_20106092_20106642 | 0.73 |
PLXDC2 |
plexin domain containing 2 |
1199 |
0.49 |
chr16_70221940_70222878 | 0.72 |
CLEC18C |
C-type lectin domain family 18, member C |
14349 |
0.1 |
chr2_60779607_60780575 | 0.72 |
BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
449 |
0.87 |
chr6_54711000_54712080 | 0.71 |
FAM83B |
family with sequence similarity 83, member B |
29 |
0.98 |
chr19_45754620_45755932 | 0.70 |
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
726 |
0.57 |
chr2_51259112_51259522 | 0.70 |
NRXN1 |
neurexin 1 |
3 |
0.99 |
chr8_121137253_121137925 | 0.69 |
COL14A1 |
collagen, type XIV, alpha 1 |
237 |
0.96 |
chrX_40004759_40006118 | 0.68 |
BCOR |
BCL6 corepressor |
444 |
0.9 |
chr13_96296247_96296898 | 0.68 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
372 |
0.89 |
chr17_29036450_29037561 | 0.68 |
ENSG00000241631 |
. |
7212 |
0.17 |
chrX_8699533_8700279 | 0.68 |
KAL1 |
Kallmann syndrome 1 sequence |
321 |
0.94 |
chr19_13906290_13907522 | 0.68 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
632 |
0.39 |
chr2_167232459_167233133 | 0.67 |
SCN9A |
sodium channel, voltage-gated, type IX, alpha subunit |
293 |
0.93 |
chr2_159825200_159826543 | 0.66 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr10_79396627_79397649 | 0.65 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
67 |
0.98 |
chr2_110872434_110873339 | 0.65 |
MALL |
mal, T-cell differentiation protein-like |
713 |
0.63 |
chr9_69785762_69786779 | 0.64 |
IGKV1OR-2 |
immunoglobulin kappa variable 1/OR-2 (pseudogene) |
8317 |
0.25 |
chr4_79472640_79473562 | 0.64 |
ANXA3 |
annexin A3 |
20 |
0.99 |
chr20_30457693_30458808 | 0.63 |
DUSP15 |
dual specificity phosphatase 15 |
125 |
0.67 |
chr16_69998972_69999655 | 0.63 |
CLEC18A |
C-type lectin domain family 18, member A |
13669 |
0.14 |
chr1_186649638_186650434 | 0.63 |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
477 |
0.89 |
chr7_5465289_5465565 | 0.62 |
TNRC18 |
trinucleotide repeat containing 18 |
382 |
0.81 |
chr6_105388737_105389249 | 0.62 |
LIN28B |
lin-28 homolog B (C. elegans) |
15930 |
0.23 |
chr14_24837426_24838101 | 0.62 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
216 |
0.85 |
chr12_54688592_54688942 | 0.62 |
NFE2 |
nuclear factor, erythroid 2 |
775 |
0.4 |
chrX_102611721_102612532 | 0.61 |
WBP5 |
WW domain binding protein 5 |
746 |
0.61 |
chr10_27148230_27149879 | 0.61 |
ABI1 |
abl-interactor 1 |
738 |
0.67 |
chr22_46366779_46367595 | 0.60 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
1408 |
0.38 |
chr16_55542879_55544136 | 0.59 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
597 |
0.77 |
chr10_18429523_18430148 | 0.58 |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
52 |
0.99 |
chr2_112897330_112897707 | 0.57 |
FBLN7 |
fibulin 7 |
1358 |
0.52 |
chr4_87516254_87516849 | 0.57 |
PTPN13 |
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
295 |
0.87 |
chr14_24020377_24021144 | 0.57 |
ZFHX2 |
zinc finger homeobox 2 |
98 |
0.94 |
chr17_1000098_1000249 | 0.57 |
ABR |
active BCR-related |
12167 |
0.2 |
chr1_120189851_120190681 | 0.57 |
ZNF697 |
zinc finger protein 697 |
130 |
0.97 |
chr2_54682726_54683239 | 0.57 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
440 |
0.88 |
chr4_168154960_168155824 | 0.56 |
SPOCK3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
25 |
0.99 |
chr4_85887529_85887946 | 0.56 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
193 |
0.97 |
chrX_54947220_54948504 | 0.55 |
TRO |
trophinin |
41 |
0.97 |
chr6_5084934_5086227 | 0.55 |
PPP1R3G |
protein phosphatase 1, regulatory subunit 3G |
140 |
0.97 |
chrX_138286572_138287296 | 0.55 |
FGF13 |
fibroblast growth factor 13 |
234 |
0.97 |
chr15_99192776_99194432 | 0.54 |
IGF1R |
insulin-like growth factor 1 receptor |
1331 |
0.47 |
chrX_39548256_39548819 | 0.54 |
ENSG00000263730 |
. |
28067 |
0.24 |
chr1_223743422_223744240 | 0.53 |
CAPN8 |
calpain 8 |
19451 |
0.25 |
chr9_35489468_35490886 | 0.53 |
RUSC2 |
RUN and SH3 domain containing 2 |
53 |
0.97 |
chrX_50556610_50557434 | 0.52 |
SHROOM4 |
shroom family member 4 |
22 |
0.99 |
chr9_124261192_124261996 | 0.52 |
ENSG00000240299 |
. |
4797 |
0.23 |
chr3_131753321_131753947 | 0.52 |
CPNE4 |
copine IV |
210 |
0.96 |
chr6_139947376_139947865 | 0.52 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
251863 |
0.02 |
chr17_21279729_21280949 | 0.51 |
KCNJ12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
830 |
0.69 |
chr1_231297648_231298418 | 0.51 |
TRIM67 |
tripartite motif containing 67 |
175 |
0.95 |
chr5_176935395_176936034 | 0.51 |
DOK3 |
docking protein 3 |
1113 |
0.32 |
chr5_1110808_1112337 | 0.51 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
578 |
0.75 |
chrX_84499187_84500398 | 0.50 |
ZNF711 |
zinc finger protein 711 |
21 |
0.94 |
chr1_36549458_36550287 | 0.50 |
TEKT2 |
tektin 2 (testicular) |
196 |
0.92 |
chr17_34611752_34612896 | 0.50 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
13395 |
0.14 |
chr11_64215600_64216212 | 0.50 |
AP003774.4 |
HCG1652096, isoform CRA_a; Uncharacterized protein; cDNA FLJ37045 fis, clone BRACE2012185 |
640 |
0.68 |
chr22_29601932_29602692 | 0.49 |
EMID1 |
EMI domain containing 1 |
400 |
0.8 |
chr1_29448339_29449190 | 0.49 |
TMEM200B |
transmembrane protein 200B |
249 |
0.93 |
chr5_71852161_71852865 | 0.49 |
ZNF366 |
zinc finger protein 366 |
48959 |
0.17 |
chr16_54320248_54320703 | 0.49 |
IRX3 |
iroquois homeobox 3 |
200 |
0.96 |
chr12_10874089_10875353 | 0.49 |
YBX3 |
Y box binding protein 3 |
1185 |
0.46 |
chr19_14315927_14317134 | 0.49 |
LPHN1 |
latrophilin 1 |
451 |
0.77 |
chr3_128207705_128209147 | 0.49 |
RP11-475N22.4 |
|
326 |
0.79 |
chr2_218843405_218844030 | 0.49 |
TNS1 |
tensin 1 |
60 |
0.79 |
chr3_87040086_87040946 | 0.49 |
VGLL3 |
vestigial like 3 (Drosophila) |
247 |
0.96 |
chr9_4763021_4763559 | 0.48 |
AK3 |
adenylate kinase 3 |
21247 |
0.16 |
chr9_127531935_127532859 | 0.48 |
RP11-175D17.3 |
|
5 |
0.95 |
chr22_22011512_22012681 | 0.48 |
KB-1440D3.13 |
|
4127 |
0.1 |
chr19_36398415_36398818 | 0.48 |
TYROBP |
TYRO protein tyrosine kinase binding protein |
533 |
0.58 |
chr2_79739509_79740065 | 0.48 |
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
339 |
0.91 |
chr10_70092145_70093579 | 0.48 |
PBLD |
phenazine biosynthesis-like protein domain containing |
56 |
0.95 |
chr11_118305386_118306890 | 0.48 |
RP11-770J1.4 |
|
217 |
0.83 |
chr1_155937673_155937906 | 0.48 |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
1731 |
0.2 |
chr11_64512499_64513555 | 0.48 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
99 |
0.95 |
chr6_166721057_166722024 | 0.48 |
PRR18 |
proline rich 18 |
331 |
0.9 |
chr2_127976513_127977351 | 0.48 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
722 |
0.74 |
chr16_67197260_67198336 | 0.48 |
HSF4 |
heat shock transcription factor 4 |
510 |
0.52 |
chr10_71812550_71812868 | 0.47 |
H2AFY2 |
H2A histone family, member Y2 |
73 |
0.98 |
chr6_35465033_35465928 | 0.47 |
TEAD3 |
TEA domain family member 3 |
627 |
0.7 |
chr11_57365224_57366004 | 0.47 |
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
338 |
0.8 |
chr16_28506747_28507012 | 0.47 |
CLN3 |
ceroid-lipofuscinosis, neuronal 3 |
24 |
0.94 |
chr7_143078673_143079796 | 0.47 |
ZYX |
zyxin |
234 |
0.85 |
chr11_117745100_117745401 | 0.47 |
FXYD6 |
FXYD domain containing ion transport regulator 6 |
2090 |
0.22 |
chr11_22214479_22215097 | 0.47 |
ANO5 |
anoctamin 5 |
66 |
0.98 |
chr12_45444664_45445224 | 0.47 |
DBX2 |
developing brain homeobox 2 |
62 |
0.76 |
chr1_33336564_33337052 | 0.47 |
FNDC5 |
fibronectin type III domain containing 5 |
394 |
0.8 |
chr5_131562588_131563831 | 0.47 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
138 |
0.96 |
chr7_5464589_5465209 | 0.47 |
TNRC18 |
trinucleotide repeat containing 18 |
146 |
0.94 |
chr6_43742717_43743167 | 0.46 |
VEGFA |
vascular endothelial growth factor A |
852 |
0.59 |
chr1_225839301_225840394 | 0.46 |
ENAH |
enabled homolog (Drosophila) |
571 |
0.78 |
chr3_117715779_117716482 | 0.46 |
LSAMP |
limbic system-associated membrane protein |
35 |
0.99 |
chr9_111034556_111034974 | 0.46 |
ENSG00000222512 |
. |
86444 |
0.11 |
chr22_29702254_29703430 | 0.46 |
GAS2L1 |
growth arrest-specific 2 like 1 |
171 |
0.91 |
chr9_113800702_113801367 | 0.46 |
LPAR1 |
lysophosphatidic acid receptor 1 |
53 |
0.98 |
chr12_111843881_111845308 | 0.46 |
SH2B3 |
SH2B adaptor protein 3 |
842 |
0.62 |
chr19_41932700_41933275 | 0.46 |
B3GNT8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
1648 |
0.18 |
chr15_48937037_48938293 | 0.46 |
FBN1 |
fibrillin 1 |
253 |
0.95 |
chr11_119019412_119020504 | 0.46 |
ABCG4 |
ATP-binding cassette, sub-family G (WHITE), member 4 |
5 |
0.94 |
chr14_78432151_78432727 | 0.46 |
ENSG00000199440 |
. |
144954 |
0.04 |
chr3_127540841_127541975 | 0.46 |
MGLL |
monoglyceride lipase |
214 |
0.96 |
chr7_107643187_107643616 | 0.45 |
LAMB1 |
laminin, beta 1 |
204 |
0.93 |
chr1_203027204_203027541 | 0.45 |
PPFIA4 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
4498 |
0.16 |
chr2_145210039_145210510 | 0.45 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
22137 |
0.25 |
chr21_34442470_34442979 | 0.45 |
OLIG1 |
oligodendrocyte transcription factor 1 |
274 |
0.77 |
chr19_54692336_54693226 | 0.45 |
MBOAT7 |
membrane bound O-acyltransferase domain containing 7 |
365 |
0.63 |
chr10_77043175_77043665 | 0.45 |
COMTD1 |
catechol-O-methyltransferase domain containing 1 |
47651 |
0.14 |
chrX_102318388_102319159 | 0.45 |
BEX1 |
brain expressed, X-linked 1 |
395 |
0.83 |
chr1_159823893_159825316 | 0.45 |
C1orf204 |
chromosome 1 open reading frame 204 |
533 |
0.6 |
chr16_66638822_66640143 | 0.44 |
CMTM3 |
CKLF-like MARVEL transmembrane domain containing 3 |
58 |
0.95 |
chr12_54784517_54785351 | 0.44 |
ZNF385A |
zinc finger protein 385A |
131 |
0.92 |
chr8_69242814_69243988 | 0.44 |
C8orf34 |
chromosome 8 open reading frame 34 |
56 |
0.82 |
chrX_152599728_152600567 | 0.44 |
ZNF275 |
zinc finger protein 275 |
534 |
0.76 |
chr2_74666737_74667617 | 0.44 |
RTKN |
rhotekin |
533 |
0.54 |
chr3_44038033_44038921 | 0.44 |
ENSG00000252980 |
. |
74102 |
0.11 |
chr7_23511015_23511471 | 0.44 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
1157 |
0.46 |
chr12_3308931_3310293 | 0.44 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr12_7037386_7038830 | 0.44 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr3_37902494_37903308 | 0.44 |
ENSG00000235257 |
. |
310 |
0.68 |
chr17_42172843_42173098 | 0.44 |
HDAC5 |
histone deacetylase 5 |
2415 |
0.15 |
chrX_119384747_119385998 | 0.44 |
ZBTB33 |
zinc finger and BTB domain containing 33 |
762 |
0.69 |
chr20_1874240_1874814 | 0.44 |
SIRPA |
signal-regulatory protein alpha |
627 |
0.78 |
chr11_76493699_76494182 | 0.43 |
RP11-21L23.3 |
|
163 |
0.71 |
chr13_72440777_72441000 | 0.43 |
DACH1 |
dachshund homolog 1 (Drosophila) |
19 |
0.99 |
chr1_205648469_205649627 | 0.43 |
SLC45A3 |
solute carrier family 45, member 3 |
539 |
0.74 |
chr13_67804057_67805835 | 0.43 |
PCDH9 |
protocadherin 9 |
478 |
0.9 |
chr8_97506014_97506898 | 0.43 |
SDC2 |
syndecan 2 |
220 |
0.96 |
chr5_127874204_127874722 | 0.43 |
FBN2 |
fibrillin 2 |
547 |
0.58 |
chr7_23510011_23510357 | 0.43 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
98 |
0.97 |
chr7_191839_192476 | 0.43 |
FAM20C |
family with sequence similarity 20, member C |
812 |
0.6 |
chrX_132548696_132549413 | 0.43 |
GPC4 |
glypican 4 |
464 |
0.88 |
chr4_4388085_4389202 | 0.43 |
NSG1 |
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
189 |
0.96 |
chr13_46960868_46961495 | 0.43 |
KIAA0226L |
KIAA0226-like |
136 |
0.96 |
chr3_159481083_159481637 | 0.43 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
142 |
0.96 |
chr12_49392080_49393040 | 0.43 |
RP11-386G11.5 |
|
379 |
0.49 |
chr10_26223696_26223953 | 0.42 |
MYO3A |
myosin IIIA |
621 |
0.65 |
chr1_15480157_15480820 | 0.42 |
TMEM51 |
transmembrane protein 51 |
203 |
0.95 |
chr10_77168132_77169350 | 0.42 |
ENSG00000237149 |
. |
5929 |
0.2 |
chr12_16500618_16501134 | 0.42 |
MGST1 |
microsomal glutathione S-transferase 1 |
145 |
0.97 |
chr10_75670529_75671818 | 0.42 |
PLAU |
plasminogen activator, urokinase |
257 |
0.89 |
chr16_3095827_3096553 | 0.42 |
MMP25 |
matrix metallopeptidase 25 |
492 |
0.51 |
chr10_81205517_81206263 | 0.42 |
ZCCHC24 |
zinc finger, CCHC domain containing 24 |
507 |
0.81 |
chr7_69065055_69065394 | 0.42 |
AUTS2 |
autism susceptibility candidate 2 |
627 |
0.81 |
chr16_3162631_3163041 | 0.42 |
ZNF205 |
zinc finger protein 205 |
40 |
0.8 |
chr7_28725956_28726399 | 0.42 |
CREB5 |
cAMP responsive element binding protein 5 |
579 |
0.86 |
chr6_47276454_47277750 | 0.42 |
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
539 |
0.86 |
chr11_17756507_17757113 | 0.42 |
KCNC1 |
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
451 |
0.83 |
chr12_72665374_72665945 | 0.42 |
ENSG00000236333 |
. |
112 |
0.93 |
chr6_17393740_17394044 | 0.41 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
2 |
0.99 |
chr10_115860454_115861476 | 0.41 |
ENSG00000253066 |
. |
10208 |
0.2 |
chr9_126780314_126780975 | 0.41 |
LHX2 |
LIM homeobox 2 |
2968 |
0.21 |
chr22_29469254_29470042 | 0.41 |
KREMEN1 |
kringle containing transmembrane protein 1 |
529 |
0.72 |
chr5_77147504_77148481 | 0.41 |
TBCA |
tubulin folding cofactor A |
16612 |
0.28 |
chr18_25756118_25756718 | 0.41 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
992 |
0.73 |
chr12_6931091_6931283 | 0.41 |
GPR162 |
G protein-coupled receptor 162 |
153 |
0.88 |
chr19_41195400_41196566 | 0.41 |
NUMBL |
numb homolog (Drosophila)-like |
44 |
0.96 |
chrX_83442690_83443328 | 0.41 |
RPS6KA6 |
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
76 |
0.98 |
chr6_42751153_42752278 | 0.41 |
GLTSCR1L |
GLTSCR1-like |
1950 |
0.31 |
chr14_65171132_65172314 | 0.41 |
PLEKHG3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
408 |
0.88 |
chr11_46300240_46300518 | 0.41 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
1151 |
0.46 |
chr7_132260669_132261651 | 0.41 |
PLXNA4 |
plexin A4 |
69 |
0.98 |
chr18_30350998_30351641 | 0.41 |
KLHL14 |
kelch-like family member 14 |
811 |
0.58 |
chr5_129240122_129240866 | 0.41 |
CHSY3 |
chondroitin sulfate synthase 3 |
329 |
0.79 |
chr5_149465776_149466139 | 0.41 |
CSF1R |
colony stimulating factor 1 receptor |
33 |
0.97 |
chr4_75718841_75720131 | 0.41 |
BTC |
betacellulin |
410 |
0.91 |
chr1_247579830_247580037 | 0.41 |
NLRP3 |
NLR family, pyrin domain containing 3 |
475 |
0.79 |
chr20_23617810_23618640 | 0.41 |
CST3 |
cystatin C |
357 |
0.87 |
chr15_47476270_47477144 | 0.41 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
chr17_76164337_76165654 | 0.41 |
SYNGR2 |
synaptogyrin 2 |
244 |
0.87 |
chr9_94579821_94580301 | 0.40 |
ROR2 |
receptor tyrosine kinase-like orphan receptor 2 |
131101 |
0.05 |
chr7_75986838_75988224 | 0.40 |
YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
817 |
0.59 |
chrX_67913478_67914353 | 0.40 |
STARD8 |
StAR-related lipid transfer (START) domain containing 8 |
422 |
0.91 |
chr14_103589830_103590609 | 0.40 |
TNFAIP2 |
tumor necrosis factor, alpha-induced protein 2 |
421 |
0.82 |
chrX_39964334_39965624 | 0.40 |
BCOR |
BCL6 corepressor |
8323 |
0.32 |
chr1_17305904_17306418 | 0.40 |
RP1-37C10.3 |
|
740 |
0.46 |
chr20_49347136_49348386 | 0.40 |
PARD6B |
par-6 family cell polarity regulator beta |
320 |
0.89 |
chr9_133536305_133536799 | 0.40 |
PRDM12 |
PR domain containing 12 |
3429 |
0.26 |
chr1_200859875_200861145 | 0.40 |
C1orf106 |
chromosome 1 open reading frame 106 |
41 |
0.97 |
chr3_197831468_197832400 | 0.40 |
AC073135.3 |
|
5143 |
0.19 |
chr1_84768320_84769315 | 0.40 |
SAMD13 |
sterile alpha motif domain containing 13 |
101 |
0.98 |
chr6_41605286_41606011 | 0.40 |
MDFI |
MyoD family inhibitor |
528 |
0.74 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 0.8 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.4 | 1.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 1.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 0.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 1.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.8 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.3 | 0.3 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 0.7 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.7 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.2 | 0.7 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.2 | 0.5 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 0.4 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 1.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 0.6 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 0.6 | GO:0021508 | floor plate formation(GO:0021508) |
0.2 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.2 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.6 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.2 | 0.6 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.5 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 1.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.6 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0031223 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.1 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0050942 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.3 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.4 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.1 | 0.4 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.8 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.7 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.3 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.6 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.6 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.4 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.2 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.9 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.1 | GO:0060180 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.3 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.7 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0048521 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian rhythm(GO:0042754) negative regulation of behavior(GO:0048521) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.2 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.2 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.6 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.1 | GO:0051940 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 0.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
0.1 | 0.3 | GO:2000794 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.8 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.2 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.3 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.1 | 0.1 | GO:0048342 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.1 | 0.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.8 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.0 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.3 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.5 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.5 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.1 | GO:0002885 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) positive regulation of hypersensitivity(GO:0002885) |
0.1 | 1.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.4 | GO:0034331 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.3 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.1 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.3 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.2 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.2 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.0 | GO:0052556 | positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
0.0 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.1 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.2 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.0 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.0 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.4 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.0 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.3 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.3 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) thermoception(GO:0050955) |
0.0 | 0.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.0 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.1 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 2.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 3.6 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0048753 | pigment granule organization(GO:0048753) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.2 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 2.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0034443 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.3 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.5 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 | 0.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0060713 | embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.0 | 0.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.1 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.0 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 2.6 | GO:0007409 | axonogenesis(GO:0007409) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.6 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.2 | 0.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 1.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.5 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.2 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 1.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.5 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 1.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 8.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.0 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 1.4 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 1.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0030313 | cell envelope(GO:0030313) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.5 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 2.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 9.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.8 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.7 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 2.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 1.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 1.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.0 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 0.3 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 5.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.1 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.4 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.2 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.0 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 1.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.0 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 1.4 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.6 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.8 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 2.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 6.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 3.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 4.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 3.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 2.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 1.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 2.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |